LHC Group, Inc. (LHCG) Shares Sold by Penn Capital Management Co. Inc.

Penn Capital Management Co. Inc. cut its stake in LHC Group, Inc. (NASDAQ:LHCG) by 24.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,340 shares of the health services provider’s stock after selling 25,973 shares during the quarter. LHC Group makes up approximately 1.1% of Penn Capital Management Co. Inc.’s investment portfolio, making the stock its 23rd largest holding. Penn Capital Management Co. Inc.’s holdings in LHC Group were worth $11,388,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Parallel Advisors LLC raised its position in shares of LHC Group by 790.0% in the first quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 237 shares during the period. Sageworth Trust Co bought a new position in shares of LHC Group in the first quarter valued at about $36,000. Financial Gravity Companies Inc. bought a new position in shares of LHC Group in the fourth quarter valued at about $49,000. Quadrant Capital Group LLC raised its position in shares of LHC Group by 1,045.7% in the first quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock valued at $57,000 after purchasing an additional 481 shares during the period. Finally, Meeder Asset Management Inc. bought a new position in shares of LHC Group in the first quarter valued at about $68,000. 94.07% of the stock is currently owned by institutional investors.

Several equities analysts have recently weighed in on the stock. Zacks Investment Research lowered shares of LHC Group from a “hold” rating to a “sell” rating in a research report on Thursday, May 2nd. UBS Group set a $133.00 price target on shares of LHC Group and gave the company a “buy” rating in a research note on Friday, May 10th. BidaskClub downgraded shares of LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 27th. Barclays lifted their target price on shares of LHC Group from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 21st. Finally, Jefferies Financial Group lifted their target price on shares of LHC Group from $125.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, May 9th. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $118.50.



NASDAQ:LHCG traded up $0.11 during mid-day trading on Wednesday, hitting $115.50. 6,293 shares of the company’s stock were exchanged, compared to its average volume of 291,507. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.57 and a quick ratio of 1.57. LHC Group, Inc. has a fifty-two week low of $73.00 and a fifty-two week high of $116.74. The company has a market cap of $3.59 billion, a PE ratio of 32.54, a P/E/G ratio of 1.94 and a beta of 0.87.

LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, topping the consensus estimate of $0.90 by $0.08. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. The business had revenue of $502.59 million for the quarter, compared to the consensus estimate of $511.16 million. Equities research analysts expect that LHC Group, Inc. will post 4.3 EPS for the current year.

In other news, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction on Friday, March 1st. The shares were sold at an average price of $108.53, for a total value of $8,139,750.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Keith G. Myers sold 5,164 shares of LHC Group stock in a transaction on Wednesday, April 3rd. The shares were sold at an average price of $108.75, for a total transaction of $561,585.00. Following the completion of the sale, the chief executive officer now owns 96,315 shares of the company’s stock, valued at approximately $10,474,256.25. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 117,876 shares of company stock valued at $12,762,540. Company insiders own 5.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “LHC Group, Inc. (LHCG) Shares Sold by Penn Capital Management Co. Inc.” was originally published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://dakotafinancialnews.com/2019/05/15/lhc-group-inc-lhcg-shares-sold-by-penn-capital-management-co-inc.html.

LHC Group Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Story: What is an overbought condition?

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.